BB Biotech AG operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BB Biotech AG with three other
financial institutions in Europe:
sales of 152.87 million Swiss Francs [US$156.31 million]
of which 94%
was Le Coq Sportif),
Gimv Investeringsmaatschappij Voor Vlanderen NV
(141.81 million Euro [US$157.39 million]
of which 43%
was Smart Industries), and
Aforti Holding SA
based in Poland
(572.01 million Polish New Zlotys [US$145.70 million]
BB Biotech AG reported sales of 150.99 million Swiss Francs (US$154.39 million)
December of 2018.
decrease of 44.1%
versus 2017, when the company's sales were 270.33 million Swiss Francs.